Teh-Ying Chou

Professor and Vice Superintendent
Taipei Medical University Hospital​

​

Dr. Teh-Ying Chou received an MD degree from National Yang-Ming Medical College, Taipei, Taiwan in 1984.  He went to Johns Hopkins University School of Medicine and received PhD in Biochemistry in 1995.  In his thesis work advised by Professor Gerald Hart and Professor Chi Dang, Dr. Chou provided the evidence of O-GlcNAc glycosylation of the oncoprotein c-Myc. From 1999 to 2001.  He completed an anatomic pathology residency at the Washington University Medical Center/Barnes-Jewish Hospital and, from 2001 to 2002, a Calendar Binford Clinical Fellowship in Pulmonary Pathology with Professor William D. Travis in Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology. 

After returning to his hometown in 2002, Teh-Yin resumed an attending pathologist position at Taipei Veterans General Hospital.  From 2014 to 2017, he served as President of the Taiwan Society of Pathology as well as Taiwan Division of International Academy of Pathology.  He is currently Professor of Graduate Institute of Clinical Medicine, Taipei Medical University and Vice Superintendent for Research and Development, Taipei Medical University Hospital, Taipei, Taiwan.

Teh-Ying has been an active member of the International Association for the Study of Lung Cancer (IASLC) and a member of the IASLC Pathology Committee since 2014.  His research topics include lung pathology, molecular pathology of lung cancer, and precision medicine of cancer.  He has been working on the molecular mechanisms of tumor metastasis and prediction and prognostication biomarkers of lung cancer and published more than 200 articles in international SCI journals.  His major contribution is pioneering digital pathology research, education, and translation for clinical diagnosis, bridging brilliant ideas, solution, and talents of next generation pathology from Taiwan to global communities.


 

Speech title & Synopsis

From Morphological to Molecular Pathology with 3D + AI

.